Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Abstracts from the Annual Pathology Conference of Victor Babeș Institute. | BMC Proc | 2026 | 41629918 | PubTator, text mining | PubMed |
| Gene regulatory network transitions reveal the central transcription factors in lung adenocarcinoma progression. | NPJ Syst Biol Appl | 2026 | 41559111 | PubTator, text mining | PubMed |
| Prognostic significance and immune landscape of anoikis-related genes in hepatocellular carcinoma: a multi-omics analysis of subtypes and cellular communication. | Clin Exp Med | 2026 | 41543595 | PubTator, text mining | PubMed |
| A distinct monocyte transcriptional state links systemic immune dysregulation to pulmonary impairment in long COVID. | Nat Immunol | 2026 | 41535626 | PubTator, text mining | PubMed |
| A structure-guided approach to noncoding variant evaluation for transcription factor binding using AlphaFold 3. | Nucleic Acids Res | 2026 | 41495882 | PubTator, text mining | PubMed |
| Pertpy: an end-to-end framework for perturbation analysis. | Nat Methods | 2026 | 41476114 | PubTator, text mining | PubMed |
| Correction to "ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer". | Adv Sci (Weinh) | 2026 | 41401362 | PubTator, text mining | PubMed |
| Mapping Molecular Diversity in Prostate Cancer With a Combined Multiplex IHC and RNA-ISH Assay. | Prostate | 2026 | 41387087 | PubTator, text mining | PubMed |
| RNPS1 Promotes the Progression of Nonsmall Cell Lung Cancer via ETV4-Mediated Ferroptosis. | DNA Cell Biol | 2026 | 41371758 | PubTator, text mining | PubMed |
| RNA-SeqEZPZ: a point-and-click pipeline for comprehensive transcriptomics analysis with interactive visualizations. | Gigascience | 2026 | 41222189 | PubTator, text mining | PubMed |
| PRC2/FOXO1-Mediated Repression Determines Interchangeability of ETS Oncogenes in Prostate Cancer and Ewing Sarcoma. | Mol Cancer Res | 2026 | 40971246 | PubTator, text mining | PubMed |
| ETV4-Mediated PD-L1 Upregulation Promotes Immune Evasion and Predicts Poor Immunotherapy Response in Melanoma. | Oncol Res | 2025 | 41502516 | PubTator, text mining | PubMed |
| ORAI3 Modulates Oral Squamous Cell Carcinoma Metastasis Through the Ca2+/Calmodulin/Calcineurin/ETV4 Signaling Pathway. | FASEB J | 2025 | 41417281 | PubTator, text mining | PubMed |
| Origin recognition complex subunit 1 functions as an oncogenic driver and therapeutic target in cancer. | Discov Oncol | 2025 | 41379386 | PubTator, text mining | PubMed |
| Transcription Factor Networks Drive Tumor Progression and Immune Microenvironment Remodeling in Hepatocellular Carcinoma. | Cancers (Basel) | 2025 | 41374989 | PubTator, text mining | PubMed |
| Identification and validation of SUN modification-related anti-PD-1 immunotherapy-resistance signatures to predict prognosis and immune microenvironment status in glioblastoma. | BMC Cancer | 2025 | 41318472 | PubTator, text mining | PubMed |
| ETV4 interacts with LOXL2 to induce epigenetic activation of NID1 during colorectal cancer progression. | Int J Biol Sci | 2025 | 41281746 | PubTator, text mining | PubMed |
| Primary ovarian CIC-rearranged sarcoma in a child: a rare case report and review of the literature. | Front Med (Lausanne) | 2025 | 41244785 | PubTator, text mining | PubMed |
| ETV4 promotes ovarian cancer growth by regulating mitochondrial function through Mfn2 ubiquitination mediated by the E3 ubiquitin ligase MARCH9. | Cell Biol Toxicol | 2025 | 41114773 | PubTator, text mining | PubMed |
| "Ewing's sarcoma of the duodenum: a rare gastrointestinal presentation": case report and review of literature. | World J Surg Oncol | 2025 | 40999465 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=3